BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Press Releases

  Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline

  May 22, 2026

   · 

  10 min read
• Press Releases

  Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations

  May 22, 2026

   · 

  5 min read
• Press Releases

  Zai Lab Announces Changes to Senior Leadership Team - May 21, 2026

  May 22, 2026

   · 

  4 min read
• Press Releases

  Medline Inc. announces pricing of upsized secondary offering of Class A common stock

  May 22, 2026

   · 

  5 min read
• Press Releases

  Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases

  May 22, 2026

   · 

  3 min read
• Press Releases

  TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study

  May 22, 2026

   · 

  3 min read
• Press Releases

  Outcome of Innate Pharma’s 2026 Annual General Meeting

  May 22, 2026

   · 

  2 min read
• Press Releases

  BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting

  May 22, 2026

   · 

  10 min read
• Press Releases

  OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer

  May 22, 2026

   · 

  6 min read
• Press Releases

  Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial

  May 22, 2026

   · 

  6 min read